Ultibro Breezhaler (indacaterol/glycopyrronium)

pCPA File Number: 20838

Negotiation Status:

Concluded with an LOI

Indication(s):

Chronic Obstructive Pulmonary Disease (COPD)

Sponsor/Manufacturer:

Novartis Pharmaceuticals Canada Inc.

CDA-AMC Project Number:

SR0369-000

pCPA Engagement Letter Issued:

2015-01-26

Negotiation Process Concluded:

2015-04-20